Premier submitted statements for the record for today’s drug pricing hearings in the Senate Finance Committee and House Committee on Oversight and Reform. As the committees begin to examine the rising cost of drugs and develop policy and oversight solutions to help lower costs for Americans, Premier urged the committees to focus on the following as overarching principles:
- Solutions that use competitive forces to lower drug prices and increase the availability of generic medications and biosimilars in the marketplace; and
- Sustainable solutions to address drug shortages that decrease barriers to entry, namely the time and cost to enter the marketplace, while maintaining the quality and safety of the product.
As an established leader in using competitive forces to lower drug prices and working towards eliminating drug shortages, Premier also made itself available as a resource for Congress as it considers policy options to address this very important issue.
About Premier, Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 165,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.